Mobile Logo
Home / News & Events

News & Events

Purna and MedPharm to Establish Trans-Atlantic Partnership to Serve Global Clients
Apr 14, 2026

Purna and MedPharm to Establish Trans-Atlantic Partnership to Serve Global Clients

Boston, MA, February 12, 2026 – Ampersand Capital Partners, a private equity firm specializing in growth investments in the life sciences and healthcare sectors, today announced its acquisition of Purna Pharmaceuticals, a…

Continue reading
MedPharm Welcomes Palvella Therapeutics’ Positive Topline Results from Its Phase 3 Study of QTORIN™ Rapamycin in Microcystic Lymphatic Malformations
MedPharm Welcomes Palvella Therapeutics’ Positive Topline Results from Its Phase 3 Study of QTORIN™ Rapamycin in Microcystic Lymphatic Malformations
Learn more
MedPharm Announces Successful U.S. FDA Inspection of its CGMP Commercial Manufacturing Facility In Durham, North Carolina
MedPharm Announces Successful U.S. FDA Inspection of its CGMP Commercial Manufacturing Facility In Durham, North Carolina
Learn more
MedPharm’s Partner Heparin Therapeutics Publishes Landmark Study on Inhaled UFH
MedPharm’s Partner Heparin Therapeutics Publishes Landmark Study on Inhaled UFH
Learn more
DCAT Week 2026 — Room #1712 at The Lotte New York Palace
Jan 29, 2026

DCAT Week 2026 — Room #1712 at The Lotte New York Palace

Continue reading
Webinar: From Concept to Market — Register Below
Webinar: From Concept to Market — Register Below
Book a meeting
MedPharm will be at Drug Delivery to the Lungs 2025 – Booth #180
MedPharm will be at Drug Delivery to the Lungs 2025 – Booth #180
Book a meeting
Medpharm will be at CPHI Americas in Philadelphia
Medpharm will be at CPHI Americas in Philadelphia
Book a meeting

All News

MedPharm Welcomes Palvella Therapeutics’ Positive Topline Results from Its Phase 3 Study of QTORIN™ Rapamycin in Microcystic Lymphatic Malformations
MedPharm Welcomes Palvella Therapeutics’ Positive Topline Results from Its Phase 3 Study of QTORIN™ Rapamycin in Microcystic Lymphatic Malformations
Learn more
Purna and MedPharm to Establish Trans-Atlantic Partnership to Serve Global Clients
Purna and MedPharm to Establish Trans-Atlantic Partnership to Serve Global Clients
Learn more
MedPharm Announces Successful U.S. FDA Inspection of its CGMP Commercial Manufacturing Facility In Durham, North Carolina
MedPharm Announces Successful U.S. FDA Inspection of its CGMP Commercial Manufacturing Facility In Durham, North Carolina
Learn more
MedPharm’s Partner Heparin Therapeutics Publishes Landmark Study on Inhaled UFH
MedPharm’s Partner Heparin Therapeutics Publishes Landmark Study on Inhaled UFH
Learn more
MedPharm Appoints Bill Humphries as Chief Executive Officer to Lead Next Phase of Strategic Growth
MedPharm Appoints Bill Humphries as Chief Executive Officer to Lead Next Phase of Strategic Growth
Learn more
MedPharm, Ltd. and Tergus Pharma Merger Forms Topical and Transepithelial CDMO Leader
MedPharm, Ltd. and Tergus Pharma Merger Forms Topical and Transepithelial CDMO Leader
Learn more
MedPharm Announces Appointment of New U.S. Director of Analytical
MedPharm Announces Appointment of New U.S. Director of Analytical
Learn more
MedPharm collaborates with Mosanna to develop new drug to tackle Metabolic Obstructive Sleep Apnea
MedPharm collaborates with Mosanna to develop new drug to tackle Metabolic Obstructive Sleep Apnea
Learn more
MedPharm Shortlisted for Two CPHI Pharma Awards
MedPharm Shortlisted for Two CPHI Pharma Awards
Learn more
Successful MHRA Audit of MedPharm Guildford
Successful MHRA Audit of MedPharm Guildford
Learn more
Webinar: From Concept to Market — Register Below
Webinar: From Concept to Market — Register Below
Book a meeting
DCAT Week 2026 — Room #1712 at The Lotte New York Palace
DCAT Week 2026 — Room #1712 at The Lotte New York Palace
Book a meeting